DGX MEXC RealStocks
Own real DGX shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-18 05:22:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Quest Diagnostics Inc. (DGX) operates in the SERVICES-MEDICAL LABORATORIES sector and is listed on NYSE. The stock is currently priced at $256.44, with a market capitalization of $28.56B and a P/E ratio of 25.64. Over the past 52 weeks, its price has ranged from $171.18 to $271.98. This page covers its latest market performance, valuation, price trends and company information.
$28.56B | |
$260.65 | |
$271.98 | |
$256.11 | |
$262.21 | |
716.83K | |
1.03M | |
25.64 | |
$271.98 | |
$171.18 | |
1.28% | |
-- |
Quest Diagnostics Inc. (DGX) last closed at $256.44 as of 2026-11-18 00:48:04, down 4.19% ($10.98) from the previous close of $262.21.
During the latest regular trading session, DGX traded between $256.11 and $271.98, with a volume of 716.83K shares. The closing price was near the lower end and near the upper end of its 52-week range.
Over the past seven days, Quest Diagnostics Inc. (DGX) moved from $255.63 to $256.44, representing a gain of 0.32% ($0.81).
The stock traded between $250.00 and $271.98 during the period. The latest price is near the lower end of the 7-day range, indicating range-bound.
The average daily volume was 811.69 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 84.6%
DGX is currently trading at $256.44, placing it 84.6% of the way from its 52-week low of $171.18 to its 52-week high of $271.98. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
| Industry | SERVICES-MEDICAL LABORATORIES |
| Employees | 57,000 |
| Exchange | NYSE |
| Company Website |
View the latest dividend and stock split events for Quest Diagnostics Inc.
Dividend | |
|---|---|
| Ex-Dividend Date | Jan 12, 2027 |
| Payment Date | Jan 27, 2027 |
| Dividend Per Share | $0.86 |
Eligible investors can buy real shares of Quest Diagnostics Inc. (DGX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to DGX, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between DGX shares and USD.
DGX Shares to USD
1.00 DGX shares = 256.438 USD
Calculations are estimates based on the latest available price and are for reference only.